Ultimo resoconto su Opexa Therapeutics Inc
Dirigenti | Titolo | Età | Da |
---|---|---|---|
R. Clifton
DFI | Director of Finance/CFO | 51 | 17/11 |
Tanya Hayden
COO | Chief Operating Officer | 44 | 01/06/21 |
John M. Klopp
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Amministratori | Titolo | Età | Da |
---|---|---|---|
R. Clifton
DFI | Director of Finance/CFO | 51 | 17/11 |
Joshua Schafer
BRD | Director/Board Member | 53 | 17/11 |
Variaz. 1 gen. | Capi. | |
---|---|---|
+20,17% | 126 Mrd | |
+24,67% | 118 Mrd | |
+22,85% | 27,87 Mrd | |
-17,74% | 20,95 Mrd | |
-16,01% | 16,92 Mrd | |
-15,21% | 16,18 Mrd | |
+11,91% | 14,84 Mrd | |
-47,10% | 14,79 Mrd | |
+54,50% | 14,08 Mrd |